Evolus Inc
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
EOLS$6.81-2.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Revenue: | ||
| Product revenue, net | $199,721 | $146,592 |
| Service revenue | 2,364 | 2,024 |
| Total net revenues | 202,085 | 148,616 |
| Operating expenses: | ||
| Product cost of sales (excludes amortization of intangible assets) | 61,559 | 55,887 |
| Selling, general and administrative | 164,944 | 141,840 |
| Research and development | 6,556 | 4,742 |
| In-process research and development | 8,869 | 2,000 |
| Revaluation of contingent royalty obligation payable to Evolus Founders | 4,257 | 5,755 |
| Depreciation and amortization | 5,133 | 3,722 |
| Total operating expenses | 251,318 | 213,946 |
| Loss from operations | (49,233) | (65,330) |
| Other income (expense): | ||
| Interest income | 860 | 119 |
| Interest expense | (13,832) | (9,097) |
| Other income (expense), net | 696 | (9) |
| Loss before income taxes: | (61,509) | (74,317) |
| Income tax expense | 176 | 95 |
| Net loss | $(61,685) | $(74,412) |
| Other comprehensive loss: | ||
| Unrealized loss, net of tax | (90) | (337) |
| Comprehensive loss | $(61,775) | $(74,749) |
| Net loss per share, basic and diluted | $(1.08) | $(1.33) |
| Weighted-average shares outstanding used to compute basic and diluted net loss per share | 56,918,721 | 56,065,297 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.